The drug, called icotrokinra and developed together with Protagonist Therapeutics, is an oral peptide designed to tamp down ...

Phase 3 NEAT clinical trial on track with 32 patients enrolled to date with majority of U.S. and European study sites now ...

In her first Mansion House speech as chancellor, Rachel Reeves is set to announce a series of regulatory changes aimed at reinforcing the UK’s position as a global financial powerhouse.

Discover how to navigate CMC processes effectively in drug development. Learn from industry leaders and ensure your project’s success. From Design Space InPharmatics LLC 13 Nov 2024 ...

There are four stages of osteoarthritis (OA): early, mild, moderate, and severe. You can also be diagnosed with a stage called pre-osteoarthritis. OA is a progressive joint disease caused by cartilage ...

Neurontin (gabapentin), generally prescribed for the treatment of nerve pain, is sometimes used to relieve severe pain caused by knee osteoarthritis (OA). Osteoarthritis, also known, as wear-and-tear ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

Global Institute of Stem Cell Therapy and Research, Inc. known as GIOSTAR, a San Diego, California based Global organization at the forefront of stem cell research over two decades, developing a novel ...

With “Momentum” as the theme of our 2023 Annual Report, learn about the incredible progress being made to support the arthritis community. Alongside patients, volunteers, partners and other ...

What is juvenile idiopathic arthritis? Juvenile idiopathic arthritis (JIA) is a form of arthritis in children. Arthritis causes joint swelling (inflammation) and joint stiffness. JIA is arthritis that ...